EUVIMEDEUVIMED entdecken
Crossref

Recombinant Methioninase Synergistically Reverses High-docetaxel Resistance Developed in Osteosarcoma Cells

Sei Morinaga, Qinghong Han, Kohei Mizuta, Byung M Kang, Michael Bouvet, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, Takashi Higuchi, Hiroyuki Tsuchiya und 2 weitere

Anticancer Research · 2024

DOI: 10.21873/anticanres.17303 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Sei Morinaga und 13 weiteren Autor:innen. Beteiligte Einrichtung: AntiCancer Inc., San Diego, CA, U.S.A. Hauptthemen laut MEDLINE: Docetaxel, Osteosarcoma, Drug Resistance, Neoplasm, Carbon-Sulfur Lyases. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DocetaxelOsteosarcomaDrug Resistance, NeoplasmCarbon-Sulfur LyasesDrug SynergismRecombinant ProteinsHumansCell Line, TumorBone NeoplasmsAntineoplastic AgentsTaxoids

Stichwörter der Autor:innen

Docetaxel resistancein vitromethioninasereversal osteosarcoma

Substanzen

DocetaxelL-methionine gamma-lyaseCarbon-Sulfur LyasesRecombinant ProteinsAntineoplastic AgentsTaxoids

Autor:innen und Institutionen

  • AntiCancer Inc., San Diego, CA, U.S.A.
  • Department of Surgery, University of California, San Diego, CA, U.S.A.
  • Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
  • AntiCancer Inc., San Diego, CA, U.S.A.; meishale@gmail.com.

Zitieren

APA

Morinaga, S., Han, Q., Mizuta, K., Kang, B. M., Bouvet, M., Yamamoto, N., Hayashi, K., Kimura, H., Miwa, S., Igarashi, K., Higuchi, T., Tsuchiya, H., Demura, S., & Hoffman, R. M. (2024). Recombinant Methioninase Synergistically Reverses High-docetaxel Resistance Developed in Osteosarcoma Cells. Anticancer Research. https://doi.org/10.21873/anticanres.17303

Vancouver

Morinaga S, Han Q, Mizuta K, Kang BM, Bouvet M, Yamamoto N, et al. Recombinant Methioninase Synergistically Reverses High-docetaxel Resistance Developed in Osteosarcoma Cells. Anticancer Research. 2024. doi:10.21873/anticanres.17303

BibTeX
@article{Morinaga2024,
  author = {Morinaga, Sei and Han, Qinghong and Mizuta, Kohei and Kang, Byung M and Bouvet, Michael and Yamamoto, Norio and Hayashi, Katsuhiro and Kimura, Hiroaki and Miwa, Shinji and Igarashi, Kentaro and Higuchi, Takashi and Tsuchiya, Hiroyuki and Demura, Satoru and Hoffman, Robert M},
  title = {Recombinant Methioninase Synergistically Reverses High-docetaxel Resistance Developed in Osteosarcoma Cells},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.17303}
}
Kostenlos starten →